Update on gestational diabetes.

As the rate of obesity increases in adolescent and adult women in the United States, practitioners of obstetrics see higher rates of gestational diabetes. Recent clinical studies suggest that women with gestational diabetes have impaired pancreatic beta-cell function and reduced beta-cell adaptation resulting in insufficient insulin secretion to maintain normal glycemia. Despite recent evidence that even mild hyperglycemia is associated with adverse pregnancy outcomes, controversies still exist in screening, management, and treatment of gestational diabetes. Initial studies regarding glyburide for treatment of gestational diabetes are promising. Overall, only about half of the women with gestational diabetes are screened in the postpartum period, an ideal time for education and intervention, to decrease incidence of glucose intolerance and progression to type 2 diabetes.
AuthorsGabriella Pridjian, Tara D Benjamin
JournalObstetrics and gynecology clinics of North America (Obstet Gynecol Clin North Am) Vol. 37 Issue 2 Pg. 255-67 (Jun 2010) ISSN: 1558-0474 [Electronic] United States
PMID20685552 (Publication Type: Journal Article, Review)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Blood Glucose
  • Hypoglycemic Agents
  • Glucose
  • Blood Glucose (analysis)
  • Diabetes, Gestational (diagnosis, metabolism, therapy)
  • Diet
  • Exercise
  • Female
  • Fetal Diseases
  • Glucose (metabolism)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Postpartum Period
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Care
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: